In vitro, myasthenia gravis antibodies have been shown to bind divalently to the nAChR, presumably via the two α-subunits of adjacent receptor monomers and thus crosslink receptors (see reviews in (Paz and Barrantes, 2019, 2021)). This evidence concerns the gene CHRNA4 and myasthenia gravis.